Respiratory disease classification

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Respiratory disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Respiratory disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Respiratory disease classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Respiratory disease classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Respiratory disease classification

CDC on Respiratory disease classification

Respiratory disease classification in the news

Blogs on Respiratory disease classification

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Respiratory disease classification

Overview

Respiratory diseases can be classified as either obstructive (i.e. conditions which impede the rate of flow into and out of the lungs, for example asthma) or restrictive (i.e. conditions which cause a reduction in the functional volume of the lungs, for example pulmonary fibrosis).

Respiratory disease can be further classified as either upper or lower respiratory tract (most commonly used in the context of infectious respiratory disease), parenchymal and vascular lung diseases.

Classification

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Diseases (COPD) are characterised by an increase in airway resistance, shown by a decrease in Peak Expiratory Flow Rate (PEFR; measured in spirometry) and Forced Expiratory Volume in 1 Second (FEV1). The Residual Volume, the volume of air left in the lungs following full expiration, is greatly increased in COPD, while the total lung volume (TLC)is normal, leading to the clinical sign of chest over-inflation in patients with severe disease. Many individuals with COPD present with "barrel chest" - a deformity of outward rib displacement due to chronic over-inflation of the lungs,also, in severe COPD, a flattening of the diaphragm can be seen on chest radiograph.

Examples of obstructive lung diseases include:

Restrictive Lung Disease

Restrictive Lung Diseases (RLD) are characterized by a loss of airway compliance [1] , causing incomplete lung expansion (i.e. via increased lung 'stiffness'). This change manifests itself in a reduced Total Lung Capacity, Inspiratory Capacity and Vital Capacity.

In contrast to OPD, RLD values for Tidal Volume, Expiratory Reserve Volume, Functional Residual Capacity and Respiratory Volume are unchanged. The FEV1 for a patient with RLD will either be normal or slightly increased, and thus the FEV1/FVC ratio will also be normal or increased for a RLD patient.

Notable restrictive lung diseases include:

Parenchymal Lung Disease

The basic functional units of the lung, the alveoli, are referred to as the lung parenchyma. Diseases such as COPD are characterised by destruction of the alveoli and are therefore referred to as parenchymal lung diseases.

Signs of parenchymal lung disease include, but are not limited to, hypoxemia (low oxygen in the blood), hypercapnoea (high carbon dioxide in the blood), and abnormal DLCO tests.

Chronic complications of parenchymal lung disease include reduced respiratory drive, right ventricular hypertrophy, and right heart failure (cor pulmonale).

As can be seen from the overlap in categories, parenchymal diseases can be either restrictive, obstructive or both.

Notable parenchymal diseases include:

Vascular Lung Disease

Vascular lung disease refers to conditions which affect the pulmonary capillary vasculature. Alterations in the vasculature manifest in a general inability to exchange blood gases such as oxygen and carbon dioxide, in the vicinity of the vascular damage (other areas of the lung may be unaffected).

Signs of vascular lung disease include, but are not limited to, hypoxemia (low oxygen in the blood) and hypercapnoea (high carbon dioxide in the blood).

Chronic complications of vascular lung disease include reduced respiratory drive, right ventricular hypertrophy, and right heart failure (cor pulmonale).

Notable vascular lung diseases include:

Infectious Respiratory Disease

Infectious Respiratory Diseases are, as the name suggests, typically caused by one of many infectious agents able to infect the mammalian respiratory system (for example the bacterium Streptococcus pneumoniae).

The clinical features and treatment options vary greatly between infectious lung disease sub-types as each type may be caused by a different infectious agent, with different pathogenesis and virulence. Features also vary between:

Respiratory Tumor

"Respiratory tumor" can refer to either neoplastic (cancerous) or non-neoplastic masses within the lungs or lung parenchyma.

Neoplastic respiratory tumors : Respiratory neoplasms are abnormal masses of tissue within the lungs or parenchyma whose cell of origin may or may not be lung tissue (many other neoplasms commonly metastasize to lung tissue). Respiratory neoplasms are most often malignant, although there are non-malignant neoplasms which can affect lung tissue.

Non-neoplastic respiratory tumors : Tuberculosis cysts, other non-neoplastic masses.

Following is another classification of respiratory tumors:

Malignant tumors

Malignant tumors, or cancers of the respiratory system, particularly lung cancers, are a major health problem responsible for 15% of all cancer diagnoses and 29% of all cancer deaths[2]. The majority of respiratory system cancers are attributable to smoking tobacco.

The major types of respiratory system cancer are:

In addition, since many cancers spread via the bloodstream and the entire cardiac output passes through the lungs, it common for cancer metastases to occur the lung. Breast cancer may invade directly through local spread, and through lymph node metastases. After metastasis to the liver, colon cancer frequently metastasizes to the lung. Prostate cancer, germ cell cancer and renal cell carcinoma may also metastasize to the lung.

Treatment of respiratory system cancer depends on the type of cancer. Surgery (usually removal of part of the lung, a lobectomy or an entire lung, a pneumonectomy), chemotherapy and radiotherapy are all used. The chance of surviving lung cancer depends on the cancer stage at the time the cancer is diagnosed and is only about 14-17% overall[3]. In the case of metastases to the lung, treatment can occasionally be curative but only in certain, rare circumstances.

Benign tumors

Benign tumours are relatively rare causes of respiratory disease. Examples of benign tumours are:

Disorders of breathing mechanics

The brain co-ordinates breathing and sends messages via nerves to the muscles of respiration. The muscles produce the movements of breathing. Disorders of the brain’s control of breathing, the nerves or the muscles of respiration can affect the respiratory system. Common disorders of breathing mechanics are:

Obesity is often associated with sleep apnea and can cause either an obstructive or a restrictive pattern on spirometry. Obesity reduces the movement of the chest wall which can, in extreme cases, result in the obesity-hypoventilation syndrome, a cause of respiratory failure.

Pulmonary vascular diseases

Pulmonary vascular diseases are conditions that affect the pulmonary circulation. Examples of these conditions are:

  • Pulmonary embolism, a blood clot that forms in a vein, breaks free, travels through the heart and lodges in the lungs (thromboembolism). Large pulmonary emboli are fatal, causing sudden death. A number of other substances can also embolise to the lungs but they are much more rare: fat embolism (particularly after bony injury), amniotic fluid embolism (with complications of labour and delivery), air embolism (iatrogenic).
  • Pulmonary arterial hypertension, elevated pressure in the pulmonary arteries. It can be idiopathic or due to the effects of another disease, particularly COPD. This can lead to strain on the right side of the heart, a condition known as cor pulmonale.
  • Pulmonary edema, leakage of fluid from capillaries of the lung into the alveoli (or air spaces). It is usually due to congestive heart failure.
  • Pulmonary hemorrhage, inflammation and damage to capillaries in the lung resulting in blood leaking into the alveoli. This may cause blood to be coughed up. Pulmonary hemorrhage can be due to auto-immune disorders such as Wegener's Granulomatosis and Goodpasture's syndrome.

Pleural cavity diseases

Pleural cavity diseases include empyema and mesothelioma which are mentioned above.

A collection of fluid in the pleural cavity is known as a pleural effusion. This may be due to fluid shifting from the bloodstream into the pleural cavity due to conditions such as congestive heart failure and cirrhosis. It may also be due to inflammation of the pleura itself as can occur with infection, pulmonary embolus, tuberculosis, mesothelioma and other conditions.

A pneumothorax is a hole in the pleura covering the lung allowing air in the lung to escape into the pleural cavity. The affected lung “collapses” like a deflated balloon. A tension pneumothorax is a particularly severe form of this condition where the air in the pleural cavity cannot escape, so the pneumothorax keeps getting bigger until it compresses the heart and blood vessels, leading to a life threatening situation.

Other Respiratory diseases

There are many other disorders that affect the lung and respiratory system. Auto-immune disorders such as vasculitis,( Wegener's Granulomatosis, Goodpasture's syndrome, for example) attack the blood vessels in the lung, causing pulmonaryhemorrhage. Disorders in swallowing,or gastric refluxing can cause aspiration pneumonia.

References

  1. Sharma, Sat. "Restrictive Lung Disease". Retrieved 2008-04-19.
  2. "LungCancer.org". Retrieved 2008-05-07.
  3. "Canadian Lung Association – Lung Cancer". Retrieved 2008-05-07.